Development and qualification of a relative potency assay for SPVN06, a recombinant AAV vector for the treatment of inherited retinal disorders-MedSci.cn

Development and qualification of a relative potency assay for SPVN06, a recombinant AAV vector for the treatment of inherited retinal disorders

Rogue, A; Massonnet, G; Dubreucq-Laine, E; Bauduin, L; Ancian, P; Vinot, PA; Marie, M; Dorange, F; Gangurde, R

HUMAN GENE THERAPY, 2022; 33 (23-24): A116

科室
- - 订阅+
  - 更多科室
工具
服务